Center for Nanomedicine, University of California, Santa Barbara, CA 93106;
Infectious and Inflammatory Diseases Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29). doi: 10.1073/pnas.2100937118.
Intestinal inflammation is the underlying basis of colitis and the inflammatory bowel diseases. These syndromes originate from genetic and environmental factors that remain to be fully identified. Infections are possible disease triggers, including recurrent human food-poisoning by the common foodborne pathogen Typhimurium (), which in laboratory mice causes progressive intestinal inflammation leading to an enduring colitis. In this colitis model, disease onset has been linked to Toll-like receptor-4-dependent induction of intestinal neuraminidase activity, leading to the desialylation, reduced half-life, and acquired deficiency of anti-inflammatory intestinal alkaline phosphatase (IAP). Neuraminidase (Neu) inhibition protected against disease onset; however, the source and identity of the Neu enzyme(s) responsible remained unknown. Herein, we report that the mammalian Neu3 neuraminidase is responsible for intestinal IAP desialylation and deficiency. Absence of Neu3 thereby prevented the accumulation of lipopolysaccharide-phosphate and inflammatory cytokine expression in providing protection against the development of severe colitis.
肠道炎症是结肠炎和炎症性肠病的根本基础。这些综合征源于尚未完全确定的遗传和环境因素。感染可能是疾病的诱因,包括常见食源性病原体 鼠伤寒沙门氏菌()引起的人类反复食物中毒,在实验小鼠中引起进行性肠道炎症,导致持续的结肠炎。在这种结肠炎模型中,疾病的发作与 Toll 样受体 4 依赖性诱导肠道神经氨酸酶活性有关,导致抗炎性肠道碱性磷酸酶(IAP)脱唾液酸化、半衰期缩短和获得性缺乏。神经氨酸酶(Neu)抑制可预防疾病发作;然而,负责的 Neu 酶(s)的来源和身份仍不清楚。本文报告称,哺乳动物 Neu3 神经氨酸酶负责肠道 IAP 的脱唾液酸化和缺乏。Neu3 的缺失从而防止了脂多糖磷酸和炎症细胞因子表达的积累,为防止严重结肠炎的发展提供了保护。